OtherCONTINUING EDUCATION
Skeletal PET with 18F-Fluoride: Applying New Technology to an Old Tracer
Frederick D. Grant, Frederic H. Fahey, Alan B. Packard, Royal T. Davis, Abass Alavi and S. Ted Treves
Journal of Nuclear Medicine January 2008, 49 (1) 68-78; DOI: https://doi.org/10.2967/jnumed.106.037200
Frederick D. Grant
Frederic H. Fahey
Alan B. Packard
Royal T. Davis
Abass Alavi
In this issue
Journal of Nuclear Medicine
Vol. 65, Issue 3
March 1, 2024
Skeletal PET with 18F-Fluoride: Applying New Technology to an Old Tracer
Frederick D. Grant, Frederic H. Fahey, Alan B. Packard, Royal T. Davis, Abass Alavi, S. Ted Treves
Journal of Nuclear Medicine Jan 2008, 49 (1) 68-78; DOI: 10.2967/jnumed.106.037200
Related Articles
Cited By...
- 18F-NaF PET/CT of Obese Patients on a Lutetium-Yttrium Oxyorthosilicate PET/CT System: Patient Dosimetry, Optimization of Injected Activity, and Acquisition Time
- 18F-Sodium Fluoride PET: History, Technical Feasibility, Mechanism of Action, Normal Biodistribution, and Diagnostic Performance in Bone Metastasis Detection Compared with Other Imaging Modalities
- Three-Hour Delayed Imaging Improves Assessment of Coronary 18F-Sodium Fluoride PET
- Characterization of Bone Lesions in Myeloma Before and During Anticancer Therapy Using 18F-FDG-PET/CT and 18F-NaF-PET/CT
- Comparison of the Variability of SUV Normalized by Skeletal Volume with the Variability of SUV Normalized by Body Weight in 18F-Fluoride PET/CT
- Assessment of Physiologic Intracranial Calcification in Healthy Adults Using 18F-NaF PET/CT
- Hospice Admission and Survival After 18F-Fluoride PET Performed for Evaluation of Osseous Metastatic Disease in the National Oncologic PET Registry
- The Role of 18F-Sodium Fluoride PET/CT Bone Scans in the Diagnosis of Metastatic Bone Disease from Breast and Prostate Cancer
- Evaluation of Prostate Cancer Bone Metastases with 18F-NaF and 18F-Fluorocholine PET/CT
- Bone-Targeted Imaging and Radionuclide Therapy in Prostate Cancer
- Prospective Study Evaluating Na18F PET/CT in Predicting Clinical Outcomes and Survival in Advanced Prostate Cancer
- 18F-Fluoride PET in the Assessment of Malignant Bone Disease
- Prognostic Factors in Patients Treated with 223Ra: The Role of Skeletal Tumor Burden on Baseline 18F-Fluoride PET/CT in Predicting Overall Survival
- Semiquantitative Analysis of the Biodistribution of the Combined 18F-NaF and 18F-FDG Administration for PET/CT Imaging
- Evaluation of 18F-Fluoride PET/MR and PET/CT in Patients with Foot Pain of Unclear Cause
- 18F-Fluoride PET Used for Treatment Monitoring of Systemic Cancer Therapy: Results from the National Oncologic PET Registry
- AEG-1 Promoter-Mediated Imaging of Prostate Cancer
- Impact of 18F-Fluoride PET on Intended Management of Patients with Cancers Other Than Prostate Cancer: Results from the National Oncologic PET Registry
- Impact of 18F-Fluoride PET in Patients with Known Prostate Cancer: Initial Results from the National Oncologic PET Registry
- Reply: Regarding Dynamic Bone Imaging with 99mTc-Labeled Diphosphonates and 18F-NaF: Mechanisms and Applications
- Bisphosphonate-Induced Osteonecrosis of the Jaw: Comparison of Disease Extent on Contrast-Enhanced MR Imaging, [18F] Fluoride PET/CT, and Conebeam CT imaging
- Dynamic Bone Imaging with 99mTc-Labeled Diphosphonates and 18F-NaF: Mechanisms and Applications
- Clinical utility of fluoride-18 positron emission tomography/CT in temporomandibular disorder with osteoarthritis: comparisons with 99mTc-MDP bone scan
- Combined 18F-Fluoride and 18F-FDG PET/CT Scanning for Evaluation of Malignancy: Results of an International Multicenter Trial
- Validation of a Paper Chromatographic Methodology as an Alternative for Determination of the Radiochemical Purity of Na18F
- Biodistribution, Tumor Detection, and Radiation Dosimetry of 18F-DCFBC, a Low-Molecular-Weight Inhibitor of Prostate-Specific Membrane Antigen, in Patients with Metastatic Prostate Cancer
- Radiation Exposure Should Not Limit Bone Scintigraphy with 18F-NaF
- Utility of 18F-Fluoride PET/CT and 18F-FDG PET/CT in the Detection of Bony Metastases in Heightened-Risk Head and Neck Cancer Patients
- The Kinetics and Reproducibility of 18F-Sodium Fluoride for Oncology Using Current PET Camera Technology
- Coronary Arterial 18F-Sodium Fluoride Uptake: A Novel Marker of Plaque Biology
- Assessment of Valvular Calcification and Inflammation by Positron Emission Tomography in Patients With Aortic Stenosis
- Nuclear Medicine in the First Year of Life
- Molecular Mechanisms of Bone 18F-NaF Deposition
- In Vivo Molecular Imaging Analysis of a Nasal Vaccine That Induces Protective Immunity against Botulism in Nonhuman Primates
- SNM Practice Guideline for Sodium 18F-Fluoride PET/CT Bone Scans 1.0
- Potential Iatrogenic Alteration to 18F-Fluoride Biodistribution
- Imaging of Back Pain in Children
- Dosimetry of Pediatric PET/CT
- Bone Metastases in Patients with Neuroendocrine Tumor: 68Ga-DOTA-Tyr3-Octreotide PET in Comparison to CT and Bone Scintigraphy
- The Role of Radiotracer Imaging in the Diagnosis and Management of Patients with Breast Cancer: Part 1--Overview, Detection, and Staging
- Radiodefluorination of 3-Fluoro-5-(2-(2-[18F](fluoromethyl)-thiazol-4-yl)ethynyl)benzonitrile ([18F]SP203), a Radioligand for Imaging Brain Metabotropic Glutamate Subtype-5 Receptors with Positron Emission Tomography, Occurs by Glutathionylation in Rat Brain